IL10 and inflammatory bowel disease: Our previous data showed that, after treatment with the antibiotic enrofloxacin, resident bacteria could be found in the spleen and liver 42 days post-infection in mice that did not produce the anti-inflammatory cytokine interleukin 10 (IL-10−/− mice), a mouse model of Inflammatory Bowel Disease (IBD).